India's Zydus Cadila to make Gilead's potential COVID-19 drug remdesivir

Zydus, listed as Cadila Healthcare, joins other Indian pharmaceutical companies Cipla Ltd, Jubilant Sciences Ltd and privately held Hetero Labs Ltd in signing non-exclusive pacts with Gilead for the drug.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2XU5qSk
via IFTTT